Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell-focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
Calico
8 followers
Vera Therapeutics
6 followers
Vaxcyte
5 followers
Discovery Life Sciences
3 followers
Mineralys Therapeutics
3 followers
MapLight Therapeutics
3 followers
Enveda Biosciences
2 followers
CG Oncology
2 followers
Aura Biosciences
2 followers
Septerna
2 followers
Bionova Scientific
2 followers
Cleveland Diagnostics
2 followers